| Total Revenue | $532.2M | CFO (prepared) |
| Adjusted EBITDA | $137.2M | CFO (prepared) |
| Adjusted EBITDA Margin | 25.8% | CEO (prepared) |
| Adjusted Diluted EPS | $0.63 | CEO (prepared) |
| Organic Revenue Growth (overall) | 2% | CEO (prepared) |
| Adjusted Organic Revenue Growth | 5% | CEO (prepared) |
| IAS Organic Revenue Growth | 4% | CEO (prepared) |
| UCTS Organic Revenue Growth | 3% | CEO (prepared) |
| MIS Organic Revenue Growth | -5% | CEO (prepared) |
| GAAP Net Loss | -$1.9M | CFO (prepared) |
| Adjusted Net Income | $89.3M | CFO (prepared) |
| Adjusted Free Cash Flow | ~$26M | CFO (prepared) |
| Net Leverage | 4.3x | CFO (prepared) |
| Q2 2026 Revenue Guidance | $485M–$490M | CFO (prepared) |
| Q2 2026 Adjusted EBITDA Guidance | $113M–$118M | CFO (prepared) |
| Q2 2026 Adjusted Diluted EPS Guidance | $0.44–$0.48 | CFO (prepared) |